Myeloproliferative Neoplasm /

Treatment Selection and Emerging Therapeutic Options in JAK-Inhibitor Refractory/ Intolerant Myelofibrosis_Srdan Verstovsek, MD, PhD

16:54

Myeloproliferative Neoplasm

Myeloproliferative Neoplasm Similar Videos

Similar Videos

Therapeutic Options for Patients with JAK-Inhibitor–Naïve Myelofibrosis_Naveen Pemmaraju, MD

21:38
New treatments for MPNs, CML, and systemic mastocytosis_Ellen Ritchie, MD; #BeyondTheCongress

17:44
Updates in the management of MDS_Michael Savona, MD; #BeyondTheCongress

16:32

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611